Immune Therapy Makes Headway Against a Lymphoma

THURSDAY, Sept. 8, 2016 -- Genetically engineered immune cells appear capable of eradicating non-Hodgkin lymphoma when coupled with effective chemotherapy, a new early trial finds. In this experimental therapy, white blood cells known as T-cells...
Source: Drugs.com - Daily MedNews - Category: Journals (General) Source Type: news